CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 625 of 637 entries

View as:

Social Work Assistance and Stipends for Housing (SASH)

Phase: N/A Priority: Normal

NCT ID: NCT05803603 Org: User:

Start: 12/01/22 End: 01/01/24 Due: 01/01/25

Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA

Phase: N/A Priority: Normal

NCT ID: NCT04166149 Org: User:

Start: 09/01/19 End: 09/06/24 Due: 09/06/25

Comparing Direct vs Indirect Methods for Cascade Screening

Phase: N/A Priority: Normal

NCT ID: NCT05348564 Org: User:

Start: 05/15/23 End: 03/31/27 Due: 03/31/28

Class 3 Biowaivers

Phase: N/A Priority: Normal

NCT ID: NCT01010698 Org: User:

Start: 06/30/09 End: 12/31/12 Due: 12/31/13

Tacrolimus to Sirolimus Conversion for Delayed Graft Function

Phase: N/A Priority: Normal

NCT ID: NCT00931255 Org: User:

Start: 04/30/09 End: 07/31/14 Due: 07/31/15

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Phase: N/A Priority: Normal

NCT ID: NCT06918977 Org: User:

Start: 05/30/25 End: 05/30/28 Due: 05/30/29

Neuroendocrine and Immune Response to Stress in Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT01975584 Org: User:

Start: 09/30/13 End: 06/30/18 Due: 06/30/19

Joint Determinants of Bone Density and CVD Calcification

Phase: N/A Priority: Normal

NCT ID: NCT00037414 Org: User:

Start: 09/30/01 End: 07/31/06 Due: 07/31/07

Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing

Phase: N/A Priority: Normal

NCT ID: NCT01026012 Org: User:

Start: 12/31/09 End: 09/30/10 Due: 09/30/11

Effects of Hesperidin on Insulin Sensitivity

Phase: N/A Priority: Normal

NCT ID: NCT01773486 Org: User:

Start: 06/30/15 End: 12/31/15 Due: 12/31/16

Predicting Effectiveness of Light Treatment for Winter Seasonal Affective Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00742365 Org: User:

Start: 11/30/07 End: 08/31/10 Due: 08/31/11

Biomarker Study of Acamprosate in Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00688324 Org: User:

Start: 06/30/08 End: 02/29/12 Due: 02/28/13

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Phase: N/A Priority: Normal

NCT ID: NCT04195438 Org: User:

Start: 05/07/14 End: 03/26/24 Due: 03/26/25

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal

NCT ID: NCT00003402 Org: User:

Start: 01/31/99 End: 12/31/02 Due: 12/31/03

Cognitive Remediation for Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00295048 Org: User:

Start: 11/30/04 End: 05/31/07 Due: 05/31/08

Biologic Mechanisms for Pain Variation After Physical Activity in Osteoarthritis

Phase: N/A Priority: Normal

NCT ID: NCT03344913 Org: User:

Start: 05/07/18 End: 08/24/22 Due: 08/24/23

Improving Cardiometabolic Health of Youth on Antipsychotic Medication

Phase: N/A Priority: Normal

NCT ID: NCT02877823 Org: User:

Start: 08/31/16 End: 12/31/21 Due: 12/31/22

Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal Tissues

Phase: N/A Priority: Normal

NCT ID: NCT04804410 Org: User:

Start: 03/31/21 End: 12/31/21 Due: 12/31/22

Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)

Phase: N/A Priority: Normal

NCT ID: NCT04235049 Org: User:

Start: 10/01/21 End: 10/30/24 Due: 10/30/25

Incisional Negative Pressure Dressing on Clean Closed Groin Incisions

Phase: N/A Priority: Normal

NCT ID: NCT02006511 Org: User:

Start: 12/01/13 End: 12/01/14 Due: 12/01/15

Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients

Phase: N/A Priority: Normal

NCT ID: NCT00176436 Org: User:

Start: 02/29/04 End: 03/31/08 Due: 03/31/09

Prebiotic Treatment in People With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT05527210 Org: User:

Start: 01/25/23 End: 01/31/26 Due: 01/31/27

Effect of Zinc on Glucose Homeostasis

Phase: N/A Priority: Normal

NCT ID: NCT05835037 Org: User:

Start: 02/16/24 End: 07/31/28 Due: 07/31/29

Indocyanine Green Tissue Perfusion Monitoring

Phase: N/A Priority: Normal

NCT ID: NCT02978560 Org: User:

Start: 03/05/18 End: 07/01/18 Due: 07/01/19

Prostate Cancer Survey

Phase: N/A Priority: Normal

NCT ID: NCT03128710 Org: User:

Start: 03/15/17 End: 02/15/18 Due: 02/15/19

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Social Work Assistance and Stipends for Housing (SASH)	NCT05803603	University of Maryland, Baltimore	user2@example.com	None	2022-12-01	2024-01-01	2025-01-01	-	-	2025-07-14
Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA	NCT04166149	University of Maryland, Baltimore	user2@example.com	None	2019-09-01	2024-09-06	2025-09-06	-	-	2025-07-14
Comparing Direct vs Indirect Methods for Cascade Screening	NCT05348564	University of Maryland, Baltimore	user2@example.com	None	2023-05-15	2027-03-31	2028-03-31	-	-	2025-07-14
Class 3 Biowaivers	NCT01010698	University of Maryland, Baltimore	user2@example.com	None	2009-06-30	2012-12-31	2013-12-31	-	-	2025-07-14
Tacrolimus to Sirolimus Conversion for Delayed Graft Function	NCT00931255	University of Maryland, Baltimore	user2@example.com	None	2009-04-30	2014-07-31	2015-07-31	-	-	2025-07-14
Improving Glycemic Control With Telemedicine and Smart Insulin Pens	NCT06918977	University of Maryland, Baltimore	user2@example.com	None	2025-05-30	2028-05-30	2029-05-30	-	-	2025-07-14
Neuroendocrine and Immune Response to Stress in Schizophrenia	NCT01975584	University of Maryland, Baltimore	user2@example.com	None	2013-09-30	2018-06-30	2019-06-30	-	-	2025-07-14
Joint Determinants of Bone Density and CVD Calcification	NCT00037414	University of Maryland, Baltimore	user2@example.com	None	2001-09-30	2006-07-31	2007-07-31	-	-	2025-07-14
Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing	NCT01026012	University of Maryland, Baltimore	user2@example.com	None	2009-12-31	2010-09-30	2011-09-30	-	-	2025-07-14
Effects of Hesperidin on Insulin Sensitivity	NCT01773486	University of Maryland, Baltimore	user2@example.com	None	2015-06-30	2015-12-31	2016-12-31	-	-	2025-07-14
Predicting Effectiveness of Light Treatment for Winter Seasonal Affective Disorder	NCT00742365	University of Maryland, Baltimore	user2@example.com	None	2007-11-30	2010-08-31	2011-08-31	-	-	2025-07-14
Biomarker Study of Acamprosate in Schizophrenia	NCT00688324	University of Maryland, Baltimore	user2@example.com	None	2008-06-30	2012-02-29	2013-02-28	-	-	2025-07-14
Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy	NCT04195438	University of Maryland, Baltimore	user2@example.com	None	2014-05-07	2024-03-26	2025-03-26	-	-	2025-07-14
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia	NCT00003402	University of Maryland, Baltimore	user2@example.com	None	1999-01-31	2002-12-31	2003-12-31	-	-	2025-07-14
Cognitive Remediation for Schizophrenia	NCT00295048	University of Maryland, Baltimore	user2@example.com	None	2004-11-30	2007-05-31	2008-05-31	-	-	2025-07-14
Biologic Mechanisms for Pain Variation After Physical Activity in Osteoarthritis	NCT03344913	University of Maryland, Baltimore	user2@example.com	None	2018-05-07	2022-08-24	2023-08-24	-	-	2025-07-14
Improving Cardiometabolic Health of Youth on Antipsychotic Medication	NCT02877823	University of Maryland, Baltimore	user2@example.com	None	2016-08-31	2021-12-31	2022-12-31	-	-	2025-07-14
Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal Tissues	NCT04804410	University of Maryland, Baltimore	user2@example.com	None	2021-03-31	2021-12-31	2022-12-31	-	-	2025-07-14
Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)	NCT04235049	University of Maryland, Baltimore	user2@example.com	None	2021-10-01	2024-10-30	2025-10-30	-	-	2025-07-14
Incisional Negative Pressure Dressing on Clean Closed Groin Incisions	NCT02006511	University of Maryland, Baltimore	user2@example.com	None	2013-12-01	2014-12-01	2015-12-01	-	-	2025-07-14
Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients	NCT00176436	University of Maryland, Baltimore	user2@example.com	None	2004-02-29	2008-03-31	2009-03-31	-	-	2025-07-14
Prebiotic Treatment in People With Schizophrenia	NCT05527210	University of Maryland, Baltimore	user2@example.com	None	2023-01-25	2026-01-31	2027-01-31	-	-	2025-07-14
Effect of Zinc on Glucose Homeostasis	NCT05835037	University of Maryland, Baltimore	user2@example.com	None	2024-02-16	2028-07-31	2029-07-31	-	-	2025-07-14
Indocyanine Green Tissue Perfusion Monitoring	NCT02978560	University of Maryland, Baltimore	user2@example.com	None	2018-03-05	2018-07-01	2019-07-01	-	-	2025-07-14
Prostate Cancer Survey	NCT03128710	University of Maryland, Baltimore	user2@example.com	None	2017-03-15	2018-02-15	2019-02-15	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance